Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03157700 · ClinicalTrials.gov registry record · NA

Interactive Technology for Media Literacy Drug Prevention in Community Groups

A NA study of Substance Use, sponsored by Real Prevention.

Completed
Registry status
NA
Development phase
642
Enrollment target
1
Study location

NCT03157700: Completed NA study of Substance Use, sponsored by Real Prevention.

NCT03157700 is a NA study of Substance Use that has completed, run by Real Prevention. The registered enrollment target is 642 participants, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03157700, a NA study of Substance Use, has completed, sponsored by Real Prevention.

COMPLETED
Registry status
NA
Development phase
642 participants
Enrollment target
1
Study location

Study Summary

This Phase II STTR will evaluate an interactive, self-paced, e-learning media literacy intervention, REAL media, to prevent youth substance use among youth in the 4-H organization. Participating 4-H clubs will be randomly assigned to use the curriculum or continue current practices with the option for delivery at the end of the study. 4-H members (ages 13-15) will complete a pretest, immediate posttest and follow-up posttests at 3 and 9 months to assess effects.

Primary Outcome

Self reported likelihood of using alcohol, cigarettes, chewing tobacco (or snuff, dip, snus, or dissolvable tobacco products), e-cigarettes, and marijuana in the following scenarios: at a party, while hanging out with friends, and while by yourself. Response options include Definitely no, No, Yes, and Definitely Yes.

Conditions Studied

Interventions

  • BEHAVIORAL REAL media curriculum

Study Locations (1)

New Jersey

  • Rutgers, The State University of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 642 participants
Start Date 2018-08-08
Est. Completion 2019-08-22
Phase NA
Real Prevention

5 total trials

What the finished NCT03157700 record still lists

NCT03157700 is an interventional study that assigns participants to a tested intervention. The registered 642 participants enrollment target is mid-sized for trials with a published cap, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (49% lower).

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which REAL media curriculum is the first listed.

NCT03157700 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT03157700 about?

NCT03157700 is a clinical study titled "Interactive Technology for Media Literacy Drug Prevention in Community Groups". This Phase II STTR will evaluate an interactive, self-paced, e-learning media literacy intervention, REAL media, to prevent youth substance use among youth in the 4-H organization. Participating 4-H clubs will be randomly assigned to use the curriculum or continue current practices with the option f...

What is the current status of trial NCT03157700?

This trial is currently completed. It is a NA study. The enrollment target is 642 participants. The study started on 2018-08-08. Estimated completion is 2019-08-22.

What conditions does trial NCT03157700 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT03157700?

The interventions under investigation include: REAL media curriculum (BEHAVIORAL).

Who is sponsoring clinical trial NCT03157700?

This trial is sponsored by Real Prevention, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03157700 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03157700's enrollment target sits among peer trials

642 14th of 88 higher than 75 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05204888 · 642 participants · NA

    myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • NCT06319820 · 641 participants · Phase 3

    A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

  • NCT06625060 · 641 participants · Phase 2

    A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

  • NCT05146297 · 644 participants · NA

    Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03157700, the US trial registry maintained by the National Library of Medicine. NCT03157700 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.